Physician profile
Jay D Sengupta
NPI 1821213562
$4,786.33
in general payments reported to CMS, 2019-2025
8 companies · $3,155 in 2025
The $3,155 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.84 · 2020: $92.21 · 2021: $18.04 · 2022: $197 · 2023: $422 · 2024: $890 · 2025: $3,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $1,732 · Travel and Lodging: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $1,732.00 |
| Travel and Lodging | $734.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,407.92 | 2020-2025 | Farapulse, Watchman Access System |
| Medtronic, INC. | $1,853.88 | 2023-2025 | Affera Mapping System, Evera Mri Xt Dr Surescan, Micra |
| Impulse Dynamics (USA) INC. | $221.31 | 2022-2023 | Optimizer |
| Biosense Webster, INC. | $141.80 | 2023 | Carto 3 |
| Abbott Laboratories | $114.32 | 2022-2024 | Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Pfizer INC. | $29.88 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $17.22 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Sengupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.